CN105326924A - Allergy-removal rhinitis cream - Google Patents

Allergy-removal rhinitis cream Download PDF

Info

Publication number
CN105326924A
CN105326924A CN201510709447.0A CN201510709447A CN105326924A CN 105326924 A CN105326924 A CN 105326924A CN 201510709447 A CN201510709447 A CN 201510709447A CN 105326924 A CN105326924 A CN 105326924A
Authority
CN
China
Prior art keywords
western medicine
quick
finished product
ointment
rhinitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510709447.0A
Other languages
Chinese (zh)
Inventor
周胜光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510709447.0A priority Critical patent/CN105326924A/en
Publication of CN105326924A publication Critical patent/CN105326924A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses allergy-removal rhinitis cream which is prepared from, by weight, 8-10% of astragalus membranaceus, 8-10% of codonopsis pilosula, 10-15% of scutellaria baicalensis, 3-5% of lumbricus, 3-5% of as arum, 3-5% of honeysuckle, 3-5% of menthol, 3-5% of radix aconiti carmichaeli and the balance finished product western medicine supplementary materials; the finished product western medicine supplementary materials comprise ketotifen, cyproheptadine, prednisone, chlortrimeton and magnesium sulfate; the traditional Chinese medicine is crushed and ground in proportion, the western medicine supplementary materials are crushed and ground in proportion, the traditional Chinese medicine ingredients and the western medicine supplementary materials are stirred and mixed, polyving akohol, sodium methyl cellulose and glycerinum are added and blended into a paste shape, and the allergy-removal rhinitis cream is obtained. The Chinese herbal medicine has the effects of clearing away heat and dispelling wind-evil, dispelling cold to dredge main and collateral channels, tonifying the lungs and the spleen, and nourishing the kidney and supplementing the yang; the finished product western medicine supplementary materials have the functions of inhibiting exudation of inflammation, lowering the permeability of blood capillary, resisting to histamine, acetyl choline and 5-hydroxytryptamine are achieved, cytomembranes of mast cells can be stabilized, and releasing of anaphylactic mediators is inhibited.

Description

One is dispelled quick rhinitis ointment
Technical field
The present invention relates to a kind of preparation for treating rhinitis, particularly relate to one and to dispel quick rhinitis ointment.
Background technology
Allergic rhinitis are that department of otorhinolaryngology commonly encountered diseases, frequently-occurring disease, its sickness rate are in rising trend in the world.Allergic rhinitis are four large primary symptoms with rhinocnesmus, sneeze, snivel, nasal obstruction clinically, simultaneously with the discomfort of eye, bottleneck throat, even cause asthma, have serious impact to minimal invasive treatment, work, study, and there is recurrent exerbation, the feature that should not effect a radical cure.
The method of current treatment has a variety of, comprises the Drug therapy of Chinese medicine, Western medicine, searching of allergen, specific immunity desensitization treatment, operative treatment etc.Because Pharmaceuticals is all independent making, adopt oral, during injection, medication is single, and treatment time is longer, and expenses for medicine is higher, and how undesirable effect is.
Summary of the invention
Based on the technical problem that background technology exists, the present invention proposes one and to dispel quick rhinitis ointment.
The present invention proposes one and to dispel quick rhinitis ointment, comprises following percentage by weight composition:
Radix Astragali 8-10%
Radix Codonopsis 8-10%
Radix Scutellariae 10-15%
Pheretima 3-5%
Herba Asari 3-5%
Flos Lonicerae 3-5%
Mentholum 3-5%
Radix Aconiti Lateralis Preparata 3-5%
Surplus is finished product Western medicine adjuvant, and finished product Western medicine adjuvant comprises ketotifen, Cyproheptadine, prednisone, chlorphenamine, magnesium sulfate; Above-mentioned Chinese medicinal ingredients is pulverized grinding in proportion, and Western medicine adjuvant pulverizes grinding in proportion, and Chinese medicinal ingredients and Western medicine adjuvant are uniformly mixed, and add polyvinyl alcohol, sodium carboxymethylcellulose pyce, glycerol reconciles into paste.
Preferably, in finished product Western medicine adjuvant, the weight ratio of ketotifen, Cyproheptadine, prednisone, chlorphenamine is 1:1:1:1.
Preferably, before quick rhinitis ointment of dispelling puts into nasal cavity, utilize disposable sterilized syringe needle cap, cut off from its pipe end 2-4 ㎜ closed and form the round straight tube of both ends open, to cut off at it with burning things which may cause a fire disaster and hold slightly preheating, pinch with finger, wipe and make it smooth.
Preferably, patient gets seat, and dispelling, quick rhinitis ointment puts into needle cap, capacity reaches more than 3/4 of pipe capacity, needle cap is put into nasal cavity middle nasal meatus position, then is about 4-6 ㎜ by disposable swab stick from rear end blank pipe and puts into, ointment is all pushed nasal cavity, allows patient's head incline slightly before.
Preferably, be blocked in prenaris with a dry cotton ball, prevent sneeze from showing effect and ointment ejection, take out cotton balls after 1 hour, and rinse with nasal nursing liquid, being used in conjunction 7 days is a course for the treatment of, and the 2nd course for the treatment of is used in drug withdrawal again after 5 days.
The selected Radix Aconiti Lateralis Preparata of prescription of the present invention, the Radix Astragali, Radix Codonopsis, Pheretima, warming YANG tonifying the lung, spleen invigorating cold expelling, sharp key of getting rid of evils, removing dampness stop tears; The combination of finished product Western medicine reaches antianaphylactic object from different pharmacological mechanisms.And the independent ketotifen or chlorphenamine or sodium chromoglicate applied grinds nasal insufflation treatment of allergic rhinitis into powder, but it is single also to there is medication, unendurable shortcoming.The number of mechanisms that the present invention is occurred by anti-allergic inflammation, the Western medicine ketotifen of a small amount of finished product, Cyproheptadine, chlorphenamine, prednisone is utilized to be auxiliary material, add Chinese medicine and be mixed and made into unguentum, based on Chinese medicine, Western medicine is auxiliary, by nasal cavity topical, Chinese and Western combines, treating both the principal and secondary aspects of a disease, reaches desirable therapeutic effect, and long-term effect is stable lasting.
The one that the present invention proposes is dispelled quick rhinitis ointment, is mainly used in perennially, the treatment of seasonal and professional allergic rhinitis; Wherein Chinese herbal medicine have that clearing away heat and expelling wind, cold expelling are sensible, tonifying the lung spleen invigorating, kidney warming and yang invigorating effect; Finished product Western medicine adjuvant has oozing out of inflammation-inhibiting, reduces the permeability of blood capillary, has antihistamine, anti-acetylcholine, the effect of medmain, can stablize the cell membrane of mastocyte, suppresses the release of Anaphylactic mediator.
The unguentum that object of the present invention adopts Chinese medicine and western medicine to be mixed mutually, be to provide that a kind of cold expelling is sensible, the Chinese herbal medicine of the kidney warming tonifying the lung spleen invigorating is main raw material, with the antianaphylactic some finished product Western medicine of minority for rhinitis unguentum made by adjuvant, make full use of the absorption function that nasal mucosa blood fortune is abundant and good, based on local application, avoid oral, the discomfort that injectable drug causes, achieve desirable therapeutic effect, and long-term effect is stable lasting.The present invention treats allergic rhinitis good absorbing, and zest is little, has no side effect, and raw material is easy to get, cheap, is highly suitable for the application of basic unit's outpatient service, clinic, rural area and remote districts, has good economic results in society.
Accompanying drawing explanation
Fig. 1 is the structural representation of injection needles head cap of the present invention.
Detailed description of the invention
Below in conjunction with specific embodiment, further explanation is done to the present invention.
Embodiment 1
The one that the present embodiment proposes is dispelled quick rhinitis ointment, comprises following percentage by weight composition: comprise following percentage by weight composition: the Radix Astragali: 8%; Radix Codonopsis: 8%; Radix Scutellariae: 10%; Pheretima: 3%; Herba Asari: 3%; Flos Lonicerae: 3%; Mentholum: 3%; Radix Aconiti Lateralis Preparata: 3%; Surplus is finished product Western medicine adjuvant.
Wherein finished product Western medicine adjuvant comprises ketotifen, Cyproheptadine, prednisone, chlorphenamine, magnesium sulfate, and wherein the weight ratio of ketotifen, Cyproheptadine, prednisone, chlorphenamine is 1:1:1:1; Above-mentioned Chinese medicinal ingredients is pulverized grinding in proportion, and Western medicine adjuvant pulverizes grinding in proportion, and Chinese medicinal ingredients and Western medicine adjuvant are uniformly mixed, and add polyvinyl alcohol, sodium carboxymethylcellulose pyce, glycerol reconciles into paste.
Embodiment 2
The one that the present embodiment proposes is dispelled quick rhinitis ointment, comprises following percentage by weight composition: comprise following percentage by weight composition: the Radix Astragali: 10%; Radix Codonopsis: 10%; Radix Scutellariae: 15%; Pheretima: 5%; Herba Asari: 5%; Flos Lonicerae: 5%; Mentholum: 5%; Radix Aconiti Lateralis Preparata: 5%; Surplus is finished product Western medicine adjuvant.
Wherein finished product Western medicine adjuvant comprises ketotifen, Cyproheptadine, prednisone, chlorphenamine, magnesium sulfate, and wherein the weight ratio of ketotifen, Cyproheptadine, prednisone, chlorphenamine is 1:1:1:1; Above-mentioned Chinese medicinal ingredients is pulverized grinding in proportion, and Western medicine adjuvant pulverizes grinding in proportion, and Chinese medicinal ingredients and Western medicine adjuvant are uniformly mixed, and add polyvinyl alcohol, sodium carboxymethylcellulose pyce, glycerol reconciles into paste.
Embodiment 3
The one that the present embodiment proposes is dispelled quick rhinitis ointment, comprises following percentage by weight composition: comprise following percentage by weight composition: the Radix Astragali: 9%; Radix Codonopsis: 9%; Radix Scutellariae: 13%; Pheretima: 4%; Herba Asari: 4%; Flos Lonicerae: 4%; Mentholum: 4%; Radix Aconiti Lateralis Preparata: 4%; Surplus is finished product Western medicine adjuvant.
Wherein finished product Western medicine adjuvant comprises ketotifen, Cyproheptadine, prednisone, chlorphenamine, magnesium sulfate, and wherein the weight ratio of ketotifen, Cyproheptadine, prednisone, chlorphenamine is 1:1:1:1; Above-mentioned Chinese medicinal ingredients is pulverized grinding in proportion, and Western medicine adjuvant pulverizes grinding in proportion, and Chinese medicinal ingredients and Western medicine adjuvant are uniformly mixed, and add polyvinyl alcohol, sodium carboxymethylcellulose pyce, glycerol reconciles into paste.
Embodiment 4
The one that the present embodiment proposes is dispelled quick rhinitis ointment, comprises following composition: comprise following composition: the Radix Astragali 8 grams; Radix Codonopsis 8 grams; Radix Scutellariae 10 grams; Pheretima 5 grams; Herba Asari 3 grams; Flos Lonicerae 5 grams; Mentholum 3 grams; Radix Aconiti Lateralis Preparata 3 grams; Surplus is finished product Western medicine adjuvant, and finished product Western medicine adjuvant comprises ketotifen 100, Cyproheptadine 100, prednisone 100, chlorphenamine 100,10 grams, magnesium sulfate; Above-mentioned Chinese medicinal ingredients is pulverized grinding in proportion, and Western medicine adjuvant pulverizes grinding in proportion, and Chinese medicinal ingredients and Western medicine adjuvant are uniformly mixed, and add polyvinyl alcohol, sodium carboxymethylcellulose pyce, glycerol reconciles into paste.
As shown in Figure 1, when the present invention uses, before quick rhinitis ointment of dispelling puts into nasal cavity, utilize 5ml disposable sterilized syringe needle cap 1, the length of needle cap is 43 ㎜, cuts off form the round straight tube of both ends open from its pipe end 3 ㎜ closed, and to cut off hold slightly preheating with alcohol burner or lighter at it, pinch with finger, wipe and make it smooth, scratch nasal mucosa when putting into nasal cavity so that shearing-proof end face is coarse and causes epistaxis.Patient gets seat, and dispelling, quick rhinitis ointment 2 puts into needle cap 1, and capacity reaches more than 3/4 of pipe capacity, and namely ointment is about 35 ㎜ in pin capped pipe.Needle cap is put into nasal cavity middle nasal meatus position, then be about 5 ㎜ by disposable swab stick 3 from rear end blank pipe and put into, ointment is all pushed nasal cavity, allows patient's head incline slightly before.Be blocked in prenaris with a dry cotton ball, prevent sneeze from showing effect and ointment ejection, take out cotton balls after 1 hour, and rinse with nasal nursing liquid, being used in conjunction 7 days is a course for the treatment of, and the 2nd course for the treatment of is used in drug withdrawal again after 5 days.
Clinical effectiveness of the present invention has complete information to add up according to the allergic rhinitis patients coming here medical, and patient 216 example of further consultation can be carried out by subscription time, the oldest is 68 years old, minimum is 12 years old, treatment time is the longest is 1 month, the shortest is 7 days, and record 7 days, 14 days, 28 days, 3 months, the change of illness state of half a year, 1 year further consultation after treatment respectively, its effective percentage is 96.15%.
Case 1: Dong patient so-and-so, female, 21 years old, rhinocnesmus, sneeze, watery nasal discharge, showed effect more than 3 years, show effect when often feeling anemofrigid cold serious, once took the treatment of Western medicine BIYANKANG, and imitated not good, now I goes to a doctor at section, to dispel quick cream, once a day, be used in conjunction 7 days, drug withdrawal was cured with one week after 5 days again.Half a year, further consultation after a year, not in recurrence.
Case 2: patient Zhao so-and-so, man, 62 years old, nasal obstruction, watery nasal discharge, sneeze more than 10 years, is diagnosed as allergic rhinitis, once row nose injection, oral drug therapy, imitates not good, increases the weight of in the recent period to examine.Quick cream of dispelling is treated, and after 7 days courses for the treatment of, symptom obviously alleviates, and second course for the treatment of is used in drug withdrawal again after 5 days, and cure after being used in conjunction 3 courses for the treatment of, half a year, after 1 year, further consultation has no recurrence.
The above; be only the present invention's preferably detailed description of the invention; but protection scope of the present invention is not limited thereto; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to according to technical scheme of the present invention and inventive concept thereof and replace or change, all should be encompassed within protection scope of the present invention.

Claims (5)

1. to dispel a quick rhinitis ointment, it is characterized in that, comprise following percentage by weight composition:
Radix Astragali 8-10%
Radix Codonopsis 8-10%
Radix Scutellariae 10-15%
Pheretima 3-5%
Herba Asari 3-5%
Flos Lonicerae 3-5%
Mentholum 3-5%
Radix Aconiti Lateralis Preparata 3-5%
Surplus is finished product Western medicine adjuvant, and finished product Western medicine adjuvant comprises ketotifen, Cyproheptadine, prednisone, chlorphenamine, magnesium sulfate; Above-mentioned Chinese medicinal ingredients is pulverized grinding in proportion, and Western medicine adjuvant pulverizes grinding in proportion, and Chinese medicinal ingredients and Western medicine adjuvant are uniformly mixed, and add polyvinyl alcohol, sodium carboxymethylcellulose pyce, glycerol reconciles into paste.
2. quick rhinitis ointment of dispelling according to claim 1, is characterized in that, in finished product Western medicine adjuvant, the weight ratio of ketotifen, Cyproheptadine, prednisone, chlorphenamine is 1:1:1:1.
3. quick rhinitis ointment of dispelling according to claim 1, it is characterized in that, before quick rhinitis ointment of dispelling puts into nasal cavity, utilize disposable sterilized syringe needle cap, the round straight tube forming both ends open is cut off from its pipe end 2-4 ㎜ closed, to cut off at it with burning things which may cause a fire disaster and hold slightly preheating, pinch with finger, wipe and make it smooth.
4. the quick rhinitis ointment of dispelling according to claim 1 or 3, it is characterized in that, patient gets seat, dispelling, quick rhinitis ointment puts into needle cap, capacity reaches more than 3/4 of pipe capacity, needle cap is put into nasal cavity middle nasal meatus position, then is about 4-6 ㎜ by disposable swab stick from rear end blank pipe and puts into, ointment is all pushed nasal cavity, allows patient's head incline slightly before.
5. quick rhinitis ointment of dispelling according to claim 4, is characterized in that, be blocked in prenaris with a dry cotton ball, prevent sneeze from showing effect and ointment ejection, take out cotton balls after 1 hour, and rinse with nasal nursing liquid, being used in conjunction 7 days is a course for the treatment of, and the 2nd course for the treatment of is used in drug withdrawal again after 5 days.
CN201510709447.0A 2015-10-28 2015-10-28 Allergy-removal rhinitis cream Pending CN105326924A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510709447.0A CN105326924A (en) 2015-10-28 2015-10-28 Allergy-removal rhinitis cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510709447.0A CN105326924A (en) 2015-10-28 2015-10-28 Allergy-removal rhinitis cream

Publications (1)

Publication Number Publication Date
CN105326924A true CN105326924A (en) 2016-02-17

Family

ID=55277830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510709447.0A Pending CN105326924A (en) 2015-10-28 2015-10-28 Allergy-removal rhinitis cream

Country Status (1)

Country Link
CN (1) CN105326924A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075234A (en) * 2016-08-08 2016-11-09 田丰 A kind of double pungent ' Biyanwan ' for treating rhinitis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320433A (en) * 2000-04-25 2001-11-07 张占军 Process for preparing powdered medicine to treat rhinitis and nasosinusitis
CN1557423A (en) * 2004-02-09 2004-12-29 辽宁中医学院 Chinese traditional medicine for treating allergic rhinitis
CN1730065A (en) * 2005-08-04 2006-02-08 刘益斌 Medicament for treating rhinitis
CN104688984A (en) * 2015-03-31 2015-06-10 杨发祥 Ointment for treating anaphylactic rhinitis and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320433A (en) * 2000-04-25 2001-11-07 张占军 Process for preparing powdered medicine to treat rhinitis and nasosinusitis
CN1557423A (en) * 2004-02-09 2004-12-29 辽宁中医学院 Chinese traditional medicine for treating allergic rhinitis
CN1730065A (en) * 2005-08-04 2006-02-08 刘益斌 Medicament for treating rhinitis
CN104688984A (en) * 2015-03-31 2015-06-10 杨发祥 Ointment for treating anaphylactic rhinitis and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘忠良等: "鼻鼽散治疗过敏性鼻炎54例", 《河南中医学院学报》 *
李洪等: "鼻炎汤治疗鼻炎、鼻窦炎", 《新中医》 *
李秀荣: "中药治疗鼻炎200例", 《辽宁中医杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075234A (en) * 2016-08-08 2016-11-09 田丰 A kind of double pungent ' Biyanwan ' for treating rhinitis

Similar Documents

Publication Publication Date Title
CN103223118B (en) Traditional Chinese medicine composition for treating facial paralysis
CN102614306B (en) Traditional Chinese herbal preparation for treating chronic nasosinusitis
CN104721764A (en) Rhinitis treating ointment
CN103251709A (en) External medicine nose through paste for treating rhinitis and preparation method thereof
CN102210819B (en) Medicament for treating anemopyretic cold and preparation method thereof
CN101138613A (en) Chinese traditional medicine for treating acute bronchitis of children
CN103142763A (en) Chinese medicinal granular preparation for treating chronic bronchitis and method for preparing same
CN105326924A (en) Allergy-removal rhinitis cream
CN106539908A (en) A kind of Chinese medicine composition for treating allergic rhinitises and skin allergy
CN102614470B (en) External Chinese herbal composition for treating sequela of apoplexy
CN105169001B (en) A kind of Chinese medicine composition for treating cough variant asthma in childhood: prednison comparing
CN103989762B (en) Chinese medicine composition of internal organs relieving cough and resolving phlegm and preparation method thereof is rushed down in a kind of heat clearing away
CN106620205A (en) Externally-used traditional Chinese medicine for foot bath to treat pediatric fever
CN104027652B (en) A kind of hypoglycemic Chinese medicine prepn and preparation method thereof
CN103211994B (en) Chinese medicament for treating chronic diarrhea
CN103006780B (en) Traditional Chinese medicinal composition for treating allergic rhinitis and method for preparing same
CN104906188A (en) External traditional Chinese medicine for treating rhinitis and preparation method of external traditional Chinese medicine
CN102000269A (en) Traditional Chinese medicine for treating cold
CN104667050A (en) Traditional Chinese medicine for treating insomnia
CN104721773A (en) Traditional Chinese medicine for treatment of rhinitis
CN103989979A (en) Traditional Chinese medicine composition for treating jaundice hepatitis
CN103566219A (en) Traditional Chinese medicine composition for treating cold
CN102940697B (en) Medicine for treating allergic rhinitis and bronchial asthma
CN101390992B (en) Asthma oral liquid and its preparing process
CN105056060A (en) Medicine for treating chronic nasosinusitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160217